Clinical Trial Update: Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder [Phase 4]

View source ↗

Summary

Phase 4 controlled trial results for brexpiprazole in patients with schizophrenia and co-occurring substance use disorder; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia
• Substance Use Disorder

Drugs mentioned

• REXULTI (brexpiprazole)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED | Results posted: 2025-05-23